At that time, NTK had sought an initial claim of 20 billion Japanese yen ($178 million) from Daiichi Sankyo as damages in November 2023, together with interest at the rate of 3% per annum.
IHH Healthcare said its unit is seeking compensation of up to 109.3 billion Indian rupees ($1.7 billion) from Japanese drugmaker Daiichi Sankyo Co Ltd for its stake buy in India’s Fortis Healthcare.
In October 2023, IHH’s subsidiary Northern TK Venture (NTK) had filed a claim against Daiichi Sankyo saying the latter prevented NTK from proceeding with its open offer to acquire a stake in Fortis Healthcare back in 2018.
